이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

CBT on Fatigue in Survivors of Hodgkin Lymphoma

2021년 4월 27일 업데이트: Anja Mehnert, University of Leipzig

Cognitive Behavioral Therapy (CBT) Web-based Intervention on Fatigue in Survivors of Hodgkin Lymphoma - a Pilot Study

Background: Cancer-related fatigue is one of the most common patient-reported impairments in survivors of Hodgkin lymphoma and is associated with adverse effects on psychological well-being and everyday life including family, work and social participation.

Methods: The investigators here present a bi-centric (Cologne and Leipzig) pilot-study for a web-based intervention (Cognitive Behavioral Therapy) on cancer-related fatigue. In detail, the investigators will conduct a non-randomized and non-controlled before-and-after study in a minimum of 20 survivors of Hodgkin lymphoma. Levels of fatigue and quality of life will be measured before the intervention (T0), post-intervention (T1) and at 3-months follow-up (T2).

Results: The investigators will provide information regarding the feasibility of the intervention (i.e., response rate, patient and therapist adherence, and patient satisfaction) and preliminary results on the efficacy of the program in reducing CRF and increasing levels of quality of life.

Aims: The results of this pilot-study will provide essential information to conduct a future randomized clinical trial to investigate the efficacy of this intervention in reducing cancer-related fatigue in survivors with Hodgkin lymphoma.

연구 개요

상세 설명

Concrete Aims: The investigators aim to conduct a a feasibility study, e.g., a pilot study before a randomized controlled trial can be planned in detail. This initial pilot-study is intended to test out the standard operating procedures, evaluate the feasibility, acceptance and adherence to the study protocol as well as preliminary efficacy of the web-based intervention for survivors of Hodgkin lymphoma. In detail, this study contains all preparation for conducting a trial, i.e., the translation, the adaptation and evaluation of the cognitive-behavioral web-based intervention manual from the original Dutch Version, the adaptation and implementation of all necessary technical and research-administrative requirements to successfully conduct the web-based randomized controlled trial and the evidence-based training of all study therapists including the implementation of therapists supervision. The investigators further assess adherence of the patients and therapists, the response rate and the patient satisfaction. Furthermore, preliminary efficacy of the intervention will be tested assessing levels of fatigue and quality of life at each measurement point.

Study Design: The design of this pilot web-based intervention on treating fatigue will be a non-randomised prospective non-controlled before-and-after study, in which observations will be made only in a patient group that receives the intervention. No control group will be recruited. Assessments will be conducted on the three measurement points: before the therapy (T0), after the intervention (T1) and 3 months after the intervention (T2).

Intervention: The internet-based cognitive behavioral therapy on postcancer fatigue includes two face-to-face sessions with their therapist and eight web-based treatment modules, each approximately 45 minutes in length, delivered over 6 months. The intervention will be specifically tailored to the individual needs of each patient: The therapy model of cancer-related fatigue distinguishes six perpetuating factors: 1) insufficient processing of being diagnosed with Hodgkin lymphoma and being treated for it; 2) excessive fear of disease recurrence; 3) inactivity or a dysregulated (physical) activity pattern; 4) dysfunctional fatigue-related beliefs; 5) dysregulated sleep-wake pattern and 6) lack of social support. For each of these six cognitive-behavioural factors that can perpetuate fatigue a treatment module has been developed. The intervention will consist of a maximum of eight treatment modules: aside from the six modules addressing the fatigue maintaining factor there is a module on goal formulation and realization of goals.

Recruitment: the recruitment will be realized on the basis of two ongoing trials of the German Hodgkin study group (HD 16- HD18) where fatigue of the patients is measured continuously.

Duration: The duration for patients will be 9 months (6 months intervention, 3 month-follow-up assessment). The duration of the whole study will be 18 months.

연구 유형

중재적

등록 (실제)

17

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Cologne, 독일
        • University Medical Center Cologne
    • Saxony
      • Leipzig, Saxony, 독일, 04103
        • University Medical Center Leipzig

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • fluency in German language
  • able to access the internet and use and follow a web-based Cognitive Behavioral intervention
  • in complete remission after treatment for newly diagnosed HL without signs of relapse (no previous relapse)
  • clinically relevant fatigue symptoms enduring at least 12 months after end of treatment (QLQ-C30 FA-12 ≥ 30 over at least two time points within the previous assessments in the course of the GHSG-trials)
  • fatigue being related to HL and its treatment and interferes with usual functioning, i.e. fulfills the definition of CRF [1, 16].

Exclusion Criteria:

  • Major communication difficulties
  • severe cognitive impairment that would interfere with a patient's ability to give informed consent for research (indicated by the medical care team)
  • Karnofsky Performance Status scale score < 70 predicting an expected survival of less than 6 months
  • somatic co-morbidities that could explain the presence of severe fatigue (e.g. Chronic Obstructive Pulmonary Disease or heart failure) according to the hemato-oncologists examining the potential participant before inclusion for the study
  • history of relapsed or refractory HL
  • clinical symptoms which may indicate a relapse of HL
  • current depressive disorder and related psychotropic or psychological treatment
  • Currently receiving medical and/or psychological treatment for a psychiatric disorder, other than the use of an anti-depressant
  • current treatment aimed at fatigue
  • previous attempt to treat fatigue with behavioral psychological therapy
  • pregnant or breastfeeding women

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Cognitive Behavioral Therapy for Treating Fatigue
This is the patient group that receives the intervention (IG), i.e., the cognitive behavioral therapy for reducing fatigue.

The internet-based CBT postcancer fatigue intervention includes two face-to-face sessions with their therapist and eight web-based treatment modules, each approximately 45 minutes in length, delivered over 6 months.

The intervention will be specifically tailored to the individual needs of each patient: The CBT model of cancer-related fatigue distinguishes six perpetuating factors: 1) insufficient processing of being diagnosed with HL and being treated for it; 2) excessive fear of disease recurrence; 3) inactivity or a dysregulated (physical) activity pattern; 4) dysfunctional fatigue-related beliefs; 5) dysregulated sleep-wake pattern and 6) lack of social support. For each of these six cognitive-behavioural factors that can perpetuate fatigue a treatment module has been developed.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
응답률
기간: 이 결과에 대한 평가 기간은 모집 시작부터 마지막 ​​환자가 포함될 때까지 약 1년이 될 것입니다.
조사관은 참여하도록 초대받은 환자의 양과 관련하여 연구에 참여할 의향이 있는 적격 환자의 양을 평가할 것입니다.
이 결과에 대한 평가 기간은 모집 시작부터 마지막 ​​환자가 포함될 때까지 약 1년이 될 것입니다.
환자 준수
기간: 약 6개월이 될 각 환자의 개입 단계 동안.
환자 순응도는 환자 이탈 문서를 통해 평가됩니다. 구체적으로 환자가 치료 중 연구를 중단하는지(그리고 있다면 어느 단계에서) 문서화할 것입니다.
약 6개월이 될 각 환자의 개입 단계 동안.
환자 만족도
기간: 환자가 개입을 완료한 직후 각 환자에 대해 한 번만 평가됩니다.
설문지에 의해 평가됨(Working Alliance Inventory - 약식 수정됨). 5점 리커트 척도로 평가된 12개 항목의 총 합계 점수가 표시됩니다(12~60 범위). 값이 높을수록 만족도가 높습니다.
환자가 개입을 완료한 직후 각 환자에 대해 한 번만 평가됩니다.
Therapist adherence
기간: Assessed during the intervention phase for each patient, i.e., within about 6 six months.
Using information of the therapy protocols of each participant, it will be assessed if the treatment sessions were done according to the treatment protocol.
Assessed during the intervention phase for each patient, i.e., within about 6 six months.

2차 결과 측정

결과 측정
측정값 설명
기간
Levels of fatigue 1
기간: Assessed at three time points: before the intervention, immediately after the intervention and 3 months after the intervention
Assessed by a questionnaire, the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Module Measuring Cancer-Related Fatigue (EORTC QLQ-FA12). The questionnaire assesses the level of cancer-related fatigue. The sum score across all 12 items, rated on a 4-point Likert scale, will be reported (total range: 12-48). Higher values indicate higher levels of fatigue (i.e., higher values indicate a worse outcome).
Assessed at three time points: before the intervention, immediately after the intervention and 3 months after the intervention
Levels of fatigue 2
기간: Assessed at three time points: before the intervention, immediately after the intervention and 3 months after the intervention
Levels of fatigue will additionally assessed by a second questionnaire, the Checklist Individual Strength - Subscale Fatigue Severity. The scale assesses the level of cancer-related fatigue. The sum score across all 8 items, rated on a 7-point Likert scale, will be presented (total range: 8 - 56). Higher values indicate higher levels of fatigue (i.e., higher values indicate a worse outcome).
Assessed at three time points: before the intervention, immediately after the intervention and 3 months after the intervention
Global quality of life
기간: Assessed at three time points: before the intervention, immediately after the intervention and 3 months after the intervention
Global quality of Life will be assessed by the European Organisation for Research and Treatment of Cancer (EORTC), Quality of Life-questionnaire (EORTC QLQ-C30). Global quality of life is assessed in a 2-item subscale of the questionnaire, each rated on a 7-point-Likert scale (total range: 2-14). According to the questionnaire manual, however, the sum score of the two items will be linear-transformed to a 0-100 scale, with higher values indicating higher levels of quality of life (i.e., higher values indicate a better outcome).
Assessed at three time points: before the intervention, immediately after the intervention and 3 months after the intervention

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Anja Mehnert, Prof. Dr., University of Leipzig
  • 수석 연구원: Peter Borchmann, Prof. Dr., University of Cologne

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2018년 8월 20일

기본 완료 (실제)

2021년 2월 28일

연구 완료 (실제)

2021년 3월 15일

연구 등록 날짜

최초 제출

2018년 8월 24일

QC 기준을 충족하는 최초 제출

2019년 5월 27일

처음 게시됨 (실제)

2019년 5월 30일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2021년 4월 28일

QC 기준을 충족하는 마지막 업데이트 제출

2021년 4월 27일

마지막으로 확인됨

2021년 4월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다